Skip to main content
Journal cover image

Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.

Publication ,  Journal Article
Autmizguine, J; Smith, PB; Prather, K; Bendel, C; Natarajan, G; Bidegain, M; Kaufman, DA; Burchfield, DJ; Ross, AS; Pandit, P; Schell, WA ...
Published in: J Antimicrob Chemother
December 1, 2018

OBJECTIVES: Extremely premature infants are at high risk of developing invasive candidiasis; fluconazole prophylaxis is safe and effective for reducing invasive candidiasis in this population but further study is needed. We sought to better understand the effect of prophylactic fluconazole on a selection of fluconazole-resistant Candida species. METHODS: We evaluated the susceptibility to fluconazole of Candida isolates from premature infants (<750 g birth weight) enrolled in a multicentre, randomized, placebo-controlled trial of fluconazole prophylaxis. Candida species were isolated through surveillance cultures at baseline (study day 0-7), period 1 (study day 8-28) and period 2 (study day 29-49). Fluconazole MICs were determined for all Candida isolates. RESULTS: Three hundred and sixty-one infants received fluconazole (n = 188) or placebo (n = 173). After the baseline period, Candida colonization was significantly lower in the fluconazole group compared with placebo during periods 1 (5% versus 27%; P < 0.001) and 2 (3% versus 27%; P < 0.001). After the baseline period, two infants (1%) were colonized with at least one fluconazole-resistant Candida in each group. Median fluconazole MIC was similar in both treatment groups at baseline and period 1. However, in period 2, median MIC was higher in the fluconazole group compared with placebo (1.00 versus 0.50 mg/L, P = 0.01). There was no emergence of resistance observed and no patients developed invasive candidiasis with a resistant Candida isolate. CONCLUSIONS: Fluconazole prophylaxis decreased Candida albicans and 'non-albicans' Candida colonization and was associated with a slightly higher fluconazole MIC for colonizing Candida isolates.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Antimicrob Chemother

DOI

EISSN

1460-2091

Publication Date

December 1, 2018

Volume

73

Issue

12

Start / End Page

3482 / 3487

Location

England

Related Subject Headings

  • Treatment Outcome
  • Placebos
  • Microbiology
  • Microbial Sensitivity Tests
  • Male
  • Infant, Premature
  • Infant, Newborn
  • Humans
  • Fluconazole
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Autmizguine, J., Smith, P. B., Prather, K., Bendel, C., Natarajan, G., Bidegain, M., … Fluconazole Prophylaxis Study Team. (2018). Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants. J Antimicrob Chemother, 73(12), 3482–3487. https://doi.org/10.1093/jac/dky353
Autmizguine, Julie, P Brian Smith, Kristi Prather, Catherine Bendel, Girija Natarajan, Margarita Bidegain, David A. Kaufman, et al. “Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.J Antimicrob Chemother 73, no. 12 (December 1, 2018): 3482–87. https://doi.org/10.1093/jac/dky353.
Autmizguine J, Smith PB, Prather K, Bendel C, Natarajan G, Bidegain M, et al. Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants. J Antimicrob Chemother. 2018 Dec 1;73(12):3482–7.
Autmizguine, Julie, et al. “Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.J Antimicrob Chemother, vol. 73, no. 12, Dec. 2018, pp. 3482–87. Pubmed, doi:10.1093/jac/dky353.
Autmizguine J, Smith PB, Prather K, Bendel C, Natarajan G, Bidegain M, Kaufman DA, Burchfield DJ, Ross AS, Pandit P, Schell WA, Gao J, Benjamin DK, Fluconazole Prophylaxis Study Team. Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants. J Antimicrob Chemother. 2018 Dec 1;73(12):3482–3487.
Journal cover image

Published In

J Antimicrob Chemother

DOI

EISSN

1460-2091

Publication Date

December 1, 2018

Volume

73

Issue

12

Start / End Page

3482 / 3487

Location

England

Related Subject Headings

  • Treatment Outcome
  • Placebos
  • Microbiology
  • Microbial Sensitivity Tests
  • Male
  • Infant, Premature
  • Infant, Newborn
  • Humans
  • Fluconazole
  • Female